1160.128.1107 Boehringer Ingelheim Investigational Site

Oklahoma City, Oklahoma

0 studies enrolling now · 1 studies all time

What they study most

Atrial Fibrillation

Studies at this site

• A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial Fibrillation — Completed